Michael Hust studied biology at the Carl von Ossietzky Universität in Oldenburg, Germany, from 1993 to 1999. He received his Ph.D. degree from the Leibniz Universität in Hannover, Germany, in 2002. Since end of 2002 he is working as group Leader at the Technische Universität Braunschweig, Germany. In 2011, he finished his professorial dissertation (Habilitation, venia legendi for biotechnology) and was appointed as Privatdozent (PD). In 2014 he was appointed as extraordinary Professor (außerplanmä ßige Professur) for biotechnology. He published more than 85 articles (including book chapters and reviews) on antibody engineering and phage display. He is working on the development of human and human-like antibodies for proteome research, diagnostics, and therapy with a focus on pathogens and toxins. Another field of work is the identification of immunogenic proteins of pathogens using phage display. He cofounded the mAb-Factory GmbH in 2007 and the Yumab GmbH in 2012.
Biography Updated on 30 January 2015